{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:18:14Z","timestamp":1792603094589,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010847","name":"Health and Family Planning Commission of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.cyto.2020.155184","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T13:31:29Z","timestamp":1594042289000},"page":"155184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"134","author":[{"given":"Fan","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cyto.2020.155184_b0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cyto.2020.155184_b0010","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s10620-009-1081-0","article-title":"Nonalcoholic fatty liver disease: a review and update","volume":"55","author":"Lewis","year":"2010","journal-title":"Dig. Dis. Sci."},{"issue":"16","key":"10.1016\/j.cyto.2020.155184_b0015","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.cyto.2020.155184_b0020","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semcancer.2013.07.003","article-title":"Obesity, insulin resistance, NASH and hepatocellular carcinoma","volume":"23","author":"Jun","year":"2013","journal-title":"Sem. Cancer Biol."},{"key":"10.1016\/j.cyto.2020.155184_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"11\u201312","key":"10.1016\/j.cyto.2020.155184_b0030","first-page":"353","article-title":"Nonalcoholic fatty liver disease \u2013 a multisystem disease?","volume":"138","author":"Mikola\u0161evi\u0107","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.cyto.2020.155184_b0035","first-page":"839","article-title":"Cardiovascular risk estimation in non alcoholic fatty liver disease","volume":"94","author":"Romdhane","year":"2016","journal-title":"Tunis. Med."},{"issue":"7","key":"10.1016\/j.cyto.2020.155184_b0040","doi-asserted-by":"crossref","first-page":"e37388","DOI":"10.5812\/hepatmon.37388","article-title":"Association of adiponectin gene polymorphisms with the risk of coronary artery disease in patients with nonalcoholic fatty liver disease in a chinese han population","volume":"16","author":"Du","year":"2016","journal-title":"Hepat. Mon."},{"issue":"1","key":"10.1016\/j.cyto.2020.155184_b0045","article-title":"The epidemiology, risk profiling and diagnostic challenges of nonalcoholic fatty liver disease","volume":"6","author":"Iqbal","year":"2019","journal-title":"Medicines (Basel)"},{"issue":"7","key":"10.1016\/j.cyto.2020.155184_b0050","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1872-034X.2011.00824.x","article-title":"NASH: A global health problem","volume":"41","author":"Sanyal","year":"2011","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.cyto.2020.155184_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2019.06.031","article-title":"Crosstalk between adipose tissue insulin resistance and liver macrophages in non alcoholic fatty liver disease","author":"Rosso","year":"2019","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.cyto.2020.155184_b0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","article-title":"Asprosin, a fasting-induced glucogenic protein hormone","volume":"165","author":"Romere","year":"2016","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cyto.2020.155184_b0065","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/09513590.2018.1512967","article-title":"Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome","volume":"35","author":"Alan","year":"2019","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.cyto.2020.155184_b0070","doi-asserted-by":"crossref","first-page":"7375294","DOI":"10.1155\/2018\/7375294","article-title":"Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases","volume":"2018","author":"Li","year":"2018","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.cyto.2020.155184_b0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1751-2980.2010.00476.x","article-title":"Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: update 2010","volume":"12","author":"Fan","year":"2011","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.cyto.2020.155184_b0080","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1053\/gast.2002.36569","article-title":"American Gastroenterological Association medical position statement: Nonalcoholic fatty liver disease","volume":"123","author":"American Gastroenterological Association","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2020.155184_b0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.gene.2019.03.070","article-title":"Expression of adipokines and their receptors in adipose tissue of women with class 3 obesity with or without hypertension","volume":"702","author":"Cano-Mart\u00ednez","year":"2019","journal-title":"Gene"},{"key":"10.1016\/j.cyto.2020.155184_b0090","article-title":"The role of adiponectin in maintaining metabolic homeostasis","author":"Adiyaman","year":"2019","journal-title":"Curr. Diabetes Rev."},{"issue":"3","key":"10.1016\/j.cyto.2020.155184_b0095","doi-asserted-by":"crossref","first-page":"e22709","DOI":"10.1002\/jcla.22709","article-title":"Low serum adiponectin is a predictor of progressing to nonalcoholic fatty liver disease","volume":"33","author":"Zhang","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"issue":"1","key":"10.1016\/j.cyto.2020.155184_b0100","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2006.10.014","article-title":"Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis","volume":"132","author":"Ota","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2020.155184_b0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cca.2017.10.034","article-title":"Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride","volume":"489","author":"Zhang","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.cyto.2020.155184_b0110","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1038\/s41598-019-42061-9","article-title":"The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients","volume":"9","author":"Chang","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.cyto.2020.155184_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1590\/S0004-28032010000200009","article-title":"Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals","volume":"47","author":"Salgado","year":"2010","journal-title":"Arq. Gastroenterol."},{"key":"10.1016\/j.cyto.2020.155184_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejim.2017.03.006","article-title":"Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?","volume":"41","author":"Gutierrez-Buey","year":"2017","journal-title":"Eur. J. Internal Med."},{"issue":"4","key":"10.1016\/j.cyto.2020.155184_b0125","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.cyto.2020.155184_b0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/jc.2012-3093","article-title":"Clinical Review: Nonalcoholic fatty liver disease: a novel cardiometabolic risk factor for type 2 diabetes and its complications","volume":"98","author":"Targher","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cyto.2020.155184_b0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2019.03.001","article-title":"Asprosin impairs insulin secretion in response to glucose and viability through TLR4\/JNK-mediated inflammation","volume":"486","author":"Lee","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"10.1016\/j.cyto.2020.155184_b0140","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1002\/jcp.26449","article-title":"WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4\/JNK signaling","volume":"233","author":"Jung","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.cyto.2020.155184_b0145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","article-title":"Adipokines and cytokines in non-alcoholic fatty liver disease","volume":"27","author":"Jarrar","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.cyto.2020.155184_b0150","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cyto.2020.155184_b0155","doi-asserted-by":"crossref","first-page":"610","DOI":"10.7150\/ijbs.29599","article-title":"Obesity, nonalcoholic fatty liver disease and adipocytokines network in promotion of cancer","volume":"15","author":"Divella","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.cyto.2020.155184_b0160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/09537104.2013.827783","article-title":"Could mean platelet volume among complete blood count parameters be a surrogate marker of metabolic syndrome in pre-pubertal children?","volume":"25","author":"Aypak","year":"2014","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.cyto.2020.155184_b0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/09537104.2011.589014","article-title":"The relationship of platelet count, mean platelet volume with metabolic syndrome according to the criteria of the American Association of Clinical Endocrinologists: a focus on gender differences","volume":"23","author":"Park","year":"2012","journal-title":"Platelets"},{"issue":"December","key":"10.1016\/j.cyto.2020.155184_b0170","first-page":"4417","article-title":"Effect of oxytocin treatment on asprosin serum level and liver function changes in rats with streptozotocin-induced diabetes","volume":"86","author":"Rania","year":"2018","journal-title":"Med. J. Cairo Univ."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:56:12Z","timestamp":1760907372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620302003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":34,"alternative-id":["S1043466620302003"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155184","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155184","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155184"}}